GEN Exclusives

More »

GEN News Highlights

More »
Aug 15, 2014

Dignify Receives SBIR Award for Bladder and Bowel Therapy

  • Dignify Therapeutics was awarded a $159,000  phase I Small Business Innovation Research (SBIR) grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (NIH).  

    Dignify is focused on restoring bladder and bowel control to people with spinal injury, spina bifida, and other neurological conditions with the aim of improving the quality-of-life for individuals that rely on bladder catheters and bowel programs for voiding. 

    “These funds will support the ongoing development of our lead product candidate, DTI-100, through the IND approval process and into clinical trials,” said Karl Thor, president and CSO.  “This SBIR award, together with future non-dilutive funding, will augment the Company’s current efforts to raise up to $3 million from private investors to develop DTI-100 through Phase II clinical trials.”   


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Block That Microbiome Metaphor!

Which way of thinking about the microbiome would best integrate the virome’s contributions?